2019
DOI: 10.1177/2047487319825917
|View full text |Cite
|
Sign up to set email alerts
|

Routine genetic testing for thoracic aortic disease may levy high costs to patients with little benefit

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…Many patients with aortic dilatation subsequently suffer from fatal aortic dissections, 1 which arise suddenly and are difficult to diagnose and treat preemptively. 2 Studies have shown that increased transforming growth factor β (TGF-β) signaling plays a role in the development of aortic dilatation. Based on this information, it was proposed that angiotensin receptor blockers (ARBs) could lower the incidence of aortic aneurysm given their ability to decrease TGF-β signaling.…”
mentioning
confidence: 99%
“…Many patients with aortic dilatation subsequently suffer from fatal aortic dissections, 1 which arise suddenly and are difficult to diagnose and treat preemptively. 2 Studies have shown that increased transforming growth factor β (TGF-β) signaling plays a role in the development of aortic dilatation. Based on this information, it was proposed that angiotensin receptor blockers (ARBs) could lower the incidence of aortic aneurysm given their ability to decrease TGF-β signaling.…”
mentioning
confidence: 99%